Formas clínicas y tratamiento de las infecciones causadas por otros hongos filamentosos

Fortún, 2011, Recomendaciones sobre el tratamiento de la enfermedad fúngica invasiva por Aspergillus spp. y otros hongos filamentosos de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Actualización 2011, Enferm Infecc Microbiol Clin, 29, 435, 10.1016/j.eimc.2011.01.010 Ruiz-Camps, 2011, Guidelines for the prevention of invasive mould diseases caused by filamentous fungi by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Clin Microbiol Infect, 17, 1, 10.1111/j.1469-0691.2011.03477.x Barberán, 2011, Recommendations for the treatment of invasive fungal infection caused by filamentous fungi in the hematological patient, Rev Esp Quimioter, 24, 263 Bhatti, 2006, Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients, Mycopathologia, 162, 1, 10.1007/s11046-006-0025-x Park, 2011, Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006, Emerg Infect Dis, 17, 1855, 10.3201/eid1710.110087 Revankar, 2006, Phaeohyphomycosis, Infect Dis Clin North Am, 20, 609, 10.1016/j.idc.2006.06.004 Richardson, 2008, Changing epidemiology of systemic fungal infections, Clin Microbiol Infect, 14, 5, 10.1111/j.1469-0691.2008.01978.x Naggie, 2009, Molds: hyalohyphomycosis, phaeohyphomycosis, and zygomycosis, Clin Chest Med, 30, 337, 10.1016/j.ccm.2009.02.009 Nucci, 2007, Fusarium infections in immunocompromised patients, Clin Microbiol Rev, 20, 695, 10.1128/CMR.00014-07 Cortez, 2008, Infections caused by Scedosporium spp, Clin Microbiol Rev, 21, 157, 10.1128/CMR.00039-07 Husain, 2005, Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome, Clin Infect Dis, 40, 89, 10.1086/426445 Nucci, 2004, Fusarium infection in hematopoietic stem cell transplant recipients, Clin Infect Dis, 38, 1237, 10.1086/383319 Pagano, 2001, Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program, Haematologica, 86, 862 Ho, 2007, Treating disseminated fusariosis: amphotericin B, voriconazole or both?, Mycoses, 50, 227, 10.1111/j.1439-0507.2006.01346.x Solé, 2009, Fungal infections after lung transplantation, Curr Opin Pulm Med, 15, 243, 10.1097/MCP.0b013e328326f410 Solé, 2011, Scedosporium apiospermum disseminated infection in a single lung transplant recipient, Rev Iberoam Micol, 28, 139, 10.1016/j.riam.2011.06.007 Pappas, 2010, Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET), Clin Infect Dis, 50, 1101, 10.1086/651262 Raad, 2006, Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions, Clin Infect Dis, 42, 1398, 10.1086/503425 Lortholary, 2010, International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole, Antimicrob Agents Chemother, 54, 4446, 10.1128/AAC.00286-10 Campo, 2010, Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009, J Infect, 60, 331, 10.1016/j.jinf.2010.01.010 Perfect, 2003, Voriconazole treatment for less-common, emerging, or refractory fungal infections, Clin Infect Dis, 36, 1122, 10.1086/374557 Fariñas, 2009, Voriconazol en otras infecciones, Rev Esp Quimioter, 2, 34 Nucci, 2003, Emerging moulds: Fusarium, Scedosporium and Zygomycetes in transplant recipients, Curr Opin Infect Dis, 16, 607, 10.1097/00001432-200312000-00015 Castón, 2011, Clinical differences between invasive pulmonary infection by Scedosporium apiospermum and invasive pulmonary aspergillosis, Mycoses, 54, e468, 10.1111/j.1439-0507.2010.01952.x Van Schooneveld, 2008, Paecilomyces lilacinus infection in a liver transplant patient: case report and review of the literature, Transpl Infect Dis, 10, 117, 10.1111/j.1399-3062.2007.00248.x Pastor, 2006, Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections, Clin Microbiol Infect, 12, 948, 10.1111/j.1469-0691.2006.01481.x Garzoni, 2008, New azoles as first line therapy for Paecilomyces lilacinus in transplant patients, Transpl Infect Dis, 10, 149, 10.1111/j.1399-3062.2007.00298.x Gonzalez, 2005, In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi, Med Mycol, 43, 281, 10.1080/13693780500088416 Kubak, 2009, AST Infectious Diseases Community of Practice. Emerging & rare fungal infections in solid organ transplant recipients, Am J Transplant, 9, S208, 10.1111/j.1600-6143.2009.02913.x Alanio, 2008, Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin, Clin Infect Dis, 46, e116, 10.1086/587750 Santillan Salas, 2011, Fatal post-operative Trichoderma longibrachiatum mediastinitis and peritonitis in a paediatric patient with complex congenital cardiac disease on peritoneal dialysis, J Med Microbiol, 60, 1869, 10.1099/jmm.0.030718-0 Lagrange-Xélot, 2008, Trichoderma fungaemia in a neutropenic patient with pulmonary cancer and human immunodeficiency virus infection, Clin Microbiol Infect, 14, 1190, 10.1111/j.1469-0691.2008.02111.x Eşel, 2003, Fatal peritonitis due to Trichoderma sp. in a patient undergoing continuous ambulatory peritoneal dialysis, Mycoses, 46, 71, 10.1046/j.1439-0507.2003.00814.x Lau, 1995, Invasive Acremonium falciforme infection in a patient with severe combined immunodeficiency, Clin Infect Dis, 20, 197, 10.1093/clinids/20.1.197 Vignon, 2011, Disseminated Scopulariopsis brevicaulis infection in an allogeneic stem cell recipient, Bone Marrow Transplant, 46, 1276, 10.1038/bmt.2010.292 Pastor, 2008, Alternaria infections: laboratory diagnosis and relevant clinical features, Clin Microbiol Infect, 14, 734, 10.1111/j.1469-0691.2008.02024.x López, 2001, Infection and colonization by Scedosporium prolificans, Enferm Infecc Microbiol Clin, 19, 308, 10.1016/S0213-005X(01)72651-1 Rodriguez-Tudela, 2009, Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases, Med Mycol, 47, 359, 10.1080/13693780802524506 Revankar, 2010, Melanized fungi in human disease, Clin Microbiol Rev, 23, 884, 10.1128/CMR.00019-10 Cornely, 2008, Aspergillus to Zygomycetes: causes, risk factors, prevention, and treatment of invasive fungal infections, Infection, 36, 296, 10.1007/s15010-008-7357-z Vigouroux, 2005, Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required, Clin Infect Dis, 40, e35, 10.1086/427752 Siwek, 2004, Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis, Clin Infect Dis, 39, 584, 10.1086/422723 Kontoyiannis, 2011, How I treat mucormycosis, Blood, 118, 1216, 10.1182/blood-2011-03-316430 Chamilos, 2008, Delaying amphotericin B based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis, Clin Infect Dis, 47, 503, 10.1086/590004 Reed, 2008, Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis, Clin Infect Dis, 47, 364, 10.1086/589857 Van Burik, 2006, Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases, Clin Infect Dis, 42, e61, 10.1086/500212 Spellberg, 2009, Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosis, Antimicrob Agents Chemother, 53, 1225, 10.1128/AAC.00361-09 Wissmann, 2010, El ser humano como reservorio de Pneumocystis, Enferm Infecc Microbiol Clin, 28, 38, 10.1016/j.eimc.2008.07.008 Kim, 2012, Outcomes of non-HIV-infected patients with Pneumocystis pneumonia and concomitant pulmonary cytomegalovirus infection, Scand J Infect Dis, 10.3109/00365548.2011.652665 Calderón, 2010, Pneumocystis infection in humans: diagnosis and treatment, Expert Rev Anti Infect Ther, 8, 683, 10.1586/eri.10.42